We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Osteoporosis Risk Linked to Variants of BMP2 Gene

By Biotechdaily staff writers
Posted on 26 Nov 2003
Researchers have reported that they have accumulated considerable evidence that points to genetic variations of the bone morphogenetic protein 2 (BMP2) gene as risk factors for osteoporosis.

Investigators at Decode Genetics (Reykjavik, Iceland) collected blood samples from over 1,000 volunteer patients across the country with low bone density or osteoporotic fractures, and used the company's population genealogy database to group them into hundreds of families with multiple patients.

Using high-density DNA genotyping, they identified a region containing the BMP2 gene on chromosome 20 that was shared by patients within the families. More...
By sequencing this region in a total of 300 patients and controls, they identified three sets of variations within, or versions of, the BMP2 gene that approximately tripled the risk of developing the osteoporosis. These findings were replicated in a Danish cohort, in which the at-risk forms of BMP2 showed a very similar correlation to the disease. Details of the study were published online on November 3, 2003, in the Public Library of Science (PloS) Biology.



Related Links:
DeCode Genetics

Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
New
Repetitive Pipette
VWR® Stepper Pro
New
HPV Molecular Test
BD Onclarity HPV Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Photo courtesy of Adobe Stock

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.